SER Archives

Comic-style illustration of Michael J. Fox pointing toward a glowing brain, alongside Parkinson’s research labs, medicines and rising stock-market arrows.

Parkinson’s Drug Stocks Enter a New Chapter as Michael J. Fox’s Mission Meets Medical Momentum -( $ABBV $IBB $SER $SUPN $XBI )

by John F. Heerdink, Jr. November 2, 2026 385Views 0Likes

Michael J. Fox’s promotion to Companion of the Order of Canada on October 2, 2026, recognized a remarkable transformation: a celebrated actor had become one of the world’s most consequential advocates for Parkinson’s research. His foundation, established in 2000, has funded approximately…

Conceptual Serina Therapeutics laboratory illustration with neurons, drug-delivery imagery and a display highlighting a potential 2027 clinical milestone.

Serina Therapeutics: A Parkinson’s Bet Where Delivery Is the Message -( $ABBV $SER )

by John F. Heerdink, Jr. October 26, 2026 250Views 0Likes

As SER-252 advances into its second dose cohort, Serina is building a case that improving how a medicine reaches patients can be as consequential as discovering the medicine itself. Serina Therapeutics, Inc. (NYSE American: SER) is pursuing an appealing proposition in biotechnology:…

Illustration of rising oil prices and investors reviewing AI financing costs for the weekly market summary ending October 23, 2026.

Weekly Market Summary, October 23, 2026: Oil Tops $100 as Wall Street Questions AI’s Financing Bill -( $EPRX $MODD $NVDA $SER $SPCX $SKHY $TSLA$MRK $MRNA )

by John F. Heerdink, Jr. October 23, 2026 227854Views 0Likes

NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.

Illustration of a circuit-covered Wall Street bull above a market chasm, beneath an AI brain and inflation tornado, with a $2 trillion label.

Weekly Market Summary – October 16, 2026: Nasdaq Falls 4.5% as AI Jitters, Inflation and a $2 Trillion Deficit Test Wall Street -( $EPRX $MODD $NVDA $SER $SPCX $TRV $TSLA )

by John F. Heerdink, Jr. October 16, 2026 181672Views 0Likes

NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.

Comic-style illustration of Michael J. Fox pointing toward Parkinson’s research and clinical trial displays, surrounded by scientists, patients and investors, with upward arrows symbolizing progress and investor optimism.

The Michael J. Fox Foundation Is Building Parkinson’s Next Chapter. Investors Have Reason to Pay Attention. -( $ABBV $IBB $SER $XBI )

by John F. Heerdink, Jr. October 8, 2026 509Views 0Likes

Better biomarkers, new FDA approvals and an emerging delivery pipeline strengthen the case for Parkinson’s innovation, with AbbVie and Serina Therapeutics offering distinct investment angles. The most compelling Parkinson’s investment story does not begin with a stock chart. It begins with a…

Investor-focused healthcare graphic showing a laboratory scene, a clinician holding a drug-delivery device, a glowing brain illustration, molecular imagery and a city skyline. The image highlights AbbVie Inc. (NYSE: ABBV) receiving FDA approval for JUVMO (tavapadon) for Parkinson’s disease and positions Serina Therapeutics Inc. (NYSE American: SER) and its SER-252 program as a potential next-generation therapy opportunity in advanced Parkinson’s disease.

AbbVie’s JUVMO Approval Puts Parkinson’s Innovation Back in Motion And Serina Therapeutics Has a Timely Opening -( $ABBV $AMRX $SER $SUPN $IBB $XBI )

by John F. Heerdink, Jr. September 29, 2026 629Views 0Likes

AbbVie Inc. (NYSE: ABBV) has secured (Sept. 28) FDA approval for JUVMO™ (tavapadon), a new once-daily Parkinson’s therapy, adding an important fresh option to a market long defined by the delicate art of managing motor symptoms, “OFF” time, dyskinesia and medication burden. For Serina…

Illustrated weekly market summary for September 25, 2026, showing a glowing green bull and rising stock chart on the left, oil pumpjacks and pipelines in the center labeled “Oil Pullback,” and a bridge made of U.S. dollar bills on the right, representing higher U.S. equities, lower crude prices and ongoing macroeconomic uncertainty.

Weekly Market Summary (Sept. 25, 2026): Stocks Gain as Oil Pullback Eases Pressure, While Treasury Yields Stay Elevated -( $AKAM $AMWL $DOCS $LPL $META $MODD $MSFT $NVDA $SER $YSG )

by John F. Heerdink, Jr. September 25, 2026 85416Views 0Likes

NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.

Promotional graphic for Tribe Public’s CEO presentation and Q&A webinar, “A New Approach to Advanced Parkinson’s Disease: Exploring SER-252’s Clinical Progress,” featuring Serina Therapeutics CEO Steven Ledger; September 24, 2026, at 8:30 a.m. PT / 11:30 a.m. ET.

Serina Therapeutics Puts Advanced Parkinson’s Disease in the Spotlight – Thursday, September 24

by John F. Heerdink, Jr. September 23, 2026 239Views 0Likes

Parkinson’s disease is one of medicine’s most stubborn commercial and scientific frontiers, and Serina Therapeutics, Inc. (NYSE American: SER) is positioning its lead program, SER-252, squarely in the middle of that opportunity. The clinical-stage biotechnology company has opened registration for a Tribe Public CEO…

Tribe Public CEO Presentation and Q&A webinar graphic featuring Serina Therapeutics CEO Steven Ledger, NYSE: SER, promoting “A New Approach to Advanced Parkinson’s Disease: Exploring SER-252’s Clinical Progress,” with a global network map, molecular imagery, and Register Now call to action.

Serina Therapeutics Brings a Fresh Dose of Momentum to Advanced Parkinson’s Care -( $SER $PFE $XBI )

by John F. Heerdink, Jr. September 21, 2026 440Views 0Likes

Serina Therapeutics, Inc. (NYSE American: SER) is approaching a consequential clinical milestone with SER-252, its long-acting POZ-apomorphine candidate for advanced Parkinson’s disease, now advancing into Cohort 2 of a registrational Phase 1b study. For many, the appeal is not simply that Serina is pursuing…

Illustration of a bullish investment landscape showing AI-powered ecommerce, healthcare innovation, cybersecurity and market growth. Robots manage online-shopping fulfillment around an ecommerce screen, clinicians and researchers work in a modern medical setting, and professionals point toward rising stock charts and upward arrows, with the phrases “AI Commerce,” “Healthcare” and “Stay Engaged.”

A Resilient Economy, AI Commerce & Healthcare Catalysts Give Many More Than One Reason to Stay Engaged -( $AMWL $AMZN $APPL $CRWD $GOOG $OKTA $PANW $PYPL $SER $SHOP $SMWB $XYZ $ZS )

by John F. Heerdink, Jr. September 14, 2026 596Views 0Likes

Many entered the week bracing for a Federal Reserve rate hike, yet the more constructive takeaway may be that policy makers still have room to choose patience. That possibility, alongside fresh evidence of AI-led ecommerce change, government-scale digital-health demand and advancing biotech milestones,…

Tag: SER

Parkinson’s Drug Stocks Enter a New Chapter as Michael J. Fox’s Mission Meets Medical Momentum -( $ABBV $IBB $SER $SUPN $XBI )

Serina Therapeutics: A Parkinson’s Bet Where Delivery Is the Message -( $ABBV $SER )

Weekly Market Summary, October 23, 2026: Oil Tops $100 as Wall Street Questions AI’s Financing Bill -( $EPRX $MODD $NVDA $SER $SPCX $SKHY $TSLA$MRK $MRNA )

Weekly Market Summary – October 16, 2026: Nasdaq Falls 4.5% as AI Jitters, Inflation and a $2 Trillion Deficit Test Wall Street -( $EPRX $MODD $NVDA $SER $SPCX $TRV $TSLA )

The Michael J. Fox Foundation Is Building Parkinson’s Next Chapter. Investors Have Reason to Pay Attention. -( $ABBV $IBB $SER $XBI )

AbbVie’s JUVMO Approval Puts Parkinson’s Innovation Back in Motion And Serina Therapeutics Has a Timely Opening -( $ABBV $AMRX $SER $SUPN $IBB $XBI )

Weekly Market Summary (Sept. 25, 2026): Stocks Gain as Oil Pullback Eases Pressure, While Treasury Yields Stay Elevated -( $AKAM $AMWL $DOCS $LPL $META $MODD $MSFT $NVDA $SER $YSG )

Serina Therapeutics Puts Advanced Parkinson’s Disease in the Spotlight – Thursday, September 24

Serina Therapeutics Brings a Fresh Dose of Momentum to Advanced Parkinson’s Care -( $SER $PFE $XBI )

A Resilient Economy, AI Commerce & Healthcare Catalysts Give Many More Than One Reason to Stay Engaged -( $AMWL $AMZN $APPL $CRWD $GOOG $OKTA $PANW $PYPL $SER $SHOP $SMWB $XYZ $ZS )

Your Guide To Staying Informed In The Markets